Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2023 39.47%
June 30, 2023 36.29%
March 31, 2023 62.13%
December 31, 2022 28.00%
September 30, 2022 18.87%
June 30, 2022 73.61%
March 31, 2022 85.78%
December 31, 2021 83.78%
September 30, 2021 78.56%
June 30, 2021 78.58%
March 31, 2021 81.77%
December 31, 2020 73.73%
September 30, 2020 80.71%
June 30, 2020 62.39%
March 31, 2020 74.00%
December 31, 2019 67.97%
September 30, 2019 65.94%
June 30, 2019 66.76%
March 31, 2019 64.96%
December 31, 2018 71.67%
September 30, 2018 60.01%
June 30, 2018 54.68%
March 31, 2018 43.88%
December 31, 2017 48.12%
September 30, 2017 47.52%
Date Value
June 30, 2017 52.27%
March 31, 2017 51.45%
December 31, 2016 50.12%
September 30, 2016 52.44%
June 30, 2016 58.14%
March 31, 2016 59.62%
December 31, 2015 65.64%
September 30, 2015 57.63%
June 30, 2015 59.29%
March 31, 2015 58.25%
December 31, 2014 57.36%
September 30, 2014 51.98%
June 30, 2014 52.79%
March 31, 2014 54.90%
December 31, 2013 54.98%
September 30, 2013 47.50%
June 30, 2013 51.41%
March 31, 2013 58.25%
December 31, 2012 60.20%
September 30, 2012 58.01%
June 30, 2012 61.15%
March 31, 2012 58.24%
December 31, 2011 58.09%
September 30, 2011 59.47%
June 30, 2011 51.56%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Johnson & Johnson 68.73%
Eli Lilly & Co. 85.78%
Lexicon Pharmaceuticals, Inc. 79.62%

Gross Profit Margin (Quarterly) Related Metrics